Literature DB >> 6982745

Haemodynamic and catecholamine response to isoflurane anaesthesia in patients undergoing coronary artery surgery.

K Balasarawathi, S N Glisson, A A El-Etr, N Mummaneni.   

Abstract

Haemodynamic and plasma catecholamine responses were evaluated during isoflurane anaesthesia in ten patients undergoing coronary artery bypass surgery. Following thiopentone induction the patients were anaesthetized with isoflurane 1.5-2.0 per cent in oxygen. The results show that after 10 minutes of isoflurane anaesthesia there was a significant increase from baseline in heart rate, 68 to 80; cardiac output, 3.75 to 4.61; and plasma epinephrine, 0.80 to 1.33 microgram/l. Conversely, there was a significant reduction in systemic vascular resistance index, 3388 to 2260, and plasma norepinephrine, 1.10 to 0.88 microgram/l. Twenty-five minutes later, after sternotomy, heart rate, cardiac output and the level of plasma epinephrine were still elevated, and systemic vascular resistance index and plasma norepinephrine remained lowered (p less than 0.05). This study demonstrates significant catecholamine responses during isoflurane anaesthesia. The increase in plasma epinephrine parallelled the increase in heart rate and cardiac output, and the decrease in plasma norepinephrine paralleled the decrease in systemic vascular resistance. Based upon these findings we conclude that catecholamine responses contribute to the cardiac and peripheral cardiovascular changes observed with isoflurane anesthesia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6982745     DOI: 10.1007/BF03007737

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  23 in total

1.  Cardiovascular effects of isoflurane in surgical patients.

Authors:  C L Graves; R W McDermott; A Bidwai
Journal:  Anesthesiology       Date:  1974-11       Impact factor: 7.892

2.  The cardiovascular effects of a new inhalation anesthetic, Forane, in human volunteers at constant arterial carbon dioxide tension.

Authors:  W C Stevens; T H Cromwell; M J Halsey; E I Eger; T F Shakespeare; S H Bahlman
Journal:  Anesthesiology       Date:  1971-07       Impact factor: 7.892

3.  Comparative metabolic responses to halogenated anaesthetics.

Authors:  A B Dobkin; P H Byles; H Y Arandia; S Ghanooni; K Nishioka; A A Levy
Journal:  Acta Anaesthesiol Scand       Date:  1972       Impact factor: 2.105

4.  Effect of pentazocine and pethidine on plasma catecholamine levels.

Authors:  T Tammisto; A Jäättelä; P Nikki; S Takki
Journal:  Ann Clin Res       Date:  1971-02

5.  Serum epinephrine and norepinephrine during valve replacement and aorta-coronary bypass.

Authors:  K Balasaraswathi; S N Glisson; A A El-Etr; R Pifarre
Journal:  Can Anaesth Soc J       Date:  1978-05

Review 6.  Isoflurane: a review.

Authors:  E I Eger
Journal:  Anesthesiology       Date:  1981-11       Impact factor: 7.892

7.  Are the myocardial functional and metabolic effects of isoflurane really different from those of halothane and enflurane?

Authors:  R G Merin
Journal:  Anesthesiology       Date:  1981-10       Impact factor: 7.892

8.  Similarity between effects of pancuronium and atropine on plasma norepinephrine levels in man.

Authors:  M F Roizen; A R Forbes; R D Miller; C R Lake; D R Stanski
Journal:  J Pharmacol Exp Ther       Date:  1979-11       Impact factor: 4.030

9.  Effect of priming volume on serum catecholamines during cardiopulmonary bypass.

Authors:  K Balasaraswathi; S N Glisson; A A El-Etr; C Azad
Journal:  Can Anaesth Soc J       Date:  1980-03

10.  Levels of circulating norepinephrine and epinephrine before, during, and after cardiopulmonary bypass in man.

Authors:  C K Tan; S N Glisson; A A El-Etr; K B Ramakrishnaiah
Journal:  J Thorac Cardiovasc Surg       Date:  1976-06       Impact factor: 5.209

View more
  1 in total

1.  Inhibition by vecuronium of carbachol-induced influx of 22Na+, 45Ca2+ and secretion of catecholamines in cultured bovine adrenal medullary cells.

Authors:  A Wada; M Arita; H Takara; K Sumikawa; Y Uezono; F Izumi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.